1 / 43

New Advances in Cardiology

New Advances in Cardiology. September 2002 – Manila, Philippines By Dr. Philip Smalley MD FRCPC Vice President and Medical Director RGA International. Objectives. Coronary disease epidemiology New cardiac risk factors and Metabolic X Syndrome Underwriting abnormal stress tests

srick
Download Presentation

New Advances in Cardiology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. New Advances in Cardiology September 2002 – Manila, Philippines By Dr. Philip Smalley MD FRCPC Vice President and Medical Director RGA International

  2. Objectives • Coronary disease epidemiology • New cardiac risk factors and Metabolic X Syndrome • Underwriting abnormal stress tests • CI heart attack claims issues with troponin use • New imaging techniques • New therapies for heart disease

  3. British Heart Foundation Health Promotion Group, University of Oxford, London, 1998

  4. British Heart Foundation Health Promotion Group, University of Oxford, London, 1998

  5. Reasons for CHD Improvements • 1985 to 1993, Hunter Region of New South Wales, Australia • Heart disease event rate reduction ( 3.3%/yr in males and 4.1%/yr in females)ALL explained by reductions in smoking, blood pressure, cholesterol, and ASA use Dobson AJ et al, J Clin Epidemiol 1999 Aug;52(8):761-71

  6. Most stringent 2 or more first degree relatives less than 55 Prevalence 2% Odds ratio 5.4 Least stringent One or more first degree relative any age Prevalence 57% Odds ratio 2.7 Family History Risk in Heart Disease Silbergerg JS, et al, Am J Epid 1998;147:1133-47

  7. Genetics of Atherosclerosis • Primitive state with conflicting small studies prone to publishing bias • Unlikely to find simple genetic polymorphisms that predict cardiovascular disease development • 36 candidate genetic defects involving: • Lipid metabolism • Coagulation cascade • Smooth-muscle proliferation and vascular growth • Inflammatory phenomena in the arterial wall • Oxidative balance in the vasculature

  8. Prognosis of Cardiomyopathy Roberts R, J Am Coll Cardiol 2000 Sep;36(3):661-7

  9. New NCEP ATP III Cholesterol Treatment Recommendations National Cholesterol Education Program,NIH Publication No. 01-3670 May 2001

  10. National Cholesterol Education Program,NIH Publication No. 01-3670 May 2001

  11. 3 of the following Table from National Cholesterol Education Program,NIH Publication No. 01-3670 May 2001

  12. Ridker PM, et al, N Engl J Med 2000 Mar 23;342(12):836-43

  13. Case – September 1999 • Applied for 2,000,000 life insurance • Stress test • 5 minutes Bruce Protocol • Peak heart rate of 150 and 144 at 1 minute recovery • Blood pressure response 140/80 rest to 130/70 at peak • 1.5 mm horizontal ST depression • Pale and dyspneic • High calcium score on Electron Beam CT

  14. Exercise Stress Test

  15. Look at all data from Stress Test • Resting ECG (lead placement different) • Exertional drop in BP has 3X CAD risk • Duration of exercise (good if > 9 min) • Timing of ST depression (worse if early and still significant if only in recovery) • Symptoms or arrhythmia reported? • Heart Rate Response? (worse if less than 12 beats recovery at 1 minute *) • Degree and slope of ST depression • Careful with computer average tracings * Cole CR et al, NEJM 1999;341(18):1351

  16. False Positive Computer Tracing Figure from Dr. Michael Baird, presented at AAIM meeting, Oct 2001

  17. Case – September 1999 • Applied for 2,000,000 life insurance • Stress test • 5 minutes Bruce Protocol • Peak heart rate of 150 and 144 at 1 minute recovery • Blood pressure response 140/80 rest to 130/70 at peak • 1.5 mm horizontal ST depression • Pale and dyspneic • High calcium score on Electron Beam CT

  18. Electron Beam CT Achenbach S, et al, NEJM, 1998 Dec 31;339(27):1964-71

  19. Prognostic Value of EBCT in Asymptomatic Subjects Increased risk of a of nonfatal MI or death or CABG if the calcium score was above a median score Figure from O'Malley PG et al, Am J Cardiol 2000 Apr 15;85(8):945-8

  20. IntraVascular UltraSound (IVUS) Cardiology Today 3D Ultrasound IVUS Imaging: MGI

  21. Magnetic Resonance Imaging • Coronary resolution not yet adequate • Accurate Ejection Fractions Laino, Charlene - MS NBC News

  22. Case – January 2000 • Admitted to hospital with 3 hours of central chest pain • Anterior MI on ECG • Normal CKMB but cardiac troponins elevated • Treated with primary angioplasty • Catheterization showed proximal LAD 95% stenosis

  23. Causing clot formation AndMyocardial Infarction Unstable Plaque that ruptures or

  24. New Cardiac Markers of Heart Attack Dufour, D. Robert, M.D. Washington VA Medical Center

  25. Impact of Troponin Use Ravkilde J, et al Scand J Clin Lab Invest 1993 Nov;53(7):677-85

  26. Cumulative Probability of Death from Cardiac Causes in Relation to Maximal Troponin T Levels Lindahl, B et al, NEJM Oct 19, 2000 Vol 343, No. 16:pg 1139-48

  27. Angioplasty and Stents Hall-Garcia Cardiology Associates - Peripheral Vascular Disease: Diagnostic & Treatment Procedures

  28. Keyhole Cardiac Surgery • Cheaper, shorter and less painful • Requires fewer blood transfusions • Reduces recovery time Picture from CardioGenesis Corporation (formerly Eclipse Surgical Technologies) Mack M.J., JAMA 2001 Feb 7;285(5):568-72

  29. Case – March 2000 • Patient again presents with unstable angina • Catheterization shows in-stent restenosis • Treated with radiation brachytherapy

  30. Brachytherapy • FDA approved for in-stent restenosis

  31. Cardiac Support Devices

  32. Insert Spider silk gene in Goat Figure from The Toronto Star, Sunday, June 9, 2002, page C1

  33. Transmyocardial Revascularization Pictures from CardioGenesis Corporation (formerly Eclipse Surgical Technologies)

  34. Rowland, Rhonda, September 14, 2001 Posted: 11:08 AM EDT (1508 GMT) Penn State Milton S. Hershey Medical Center College of Medicine

  35. Robotic Surgery Picture from Mack M.J., JAMA. 2001;285:568-572

  36. http://bmj.com/cgi/content/full/324/7328/31?lookupType=volpage&vol=324&fp=31&view=shorthttp://bmj.com/cgi/content/full/324/7328/31?lookupType=volpage&vol=324&fp=31&view=short

  37. Pharmocogenetics • Recombinant DNA therapy to make pure proteins • insulin, growth hormone, blood clotting factors, erythropoietin etc. • Tailored drug therapies guided by patients genetic profile • Avoid certain class of drugs if patient has genetic susceptibility to side effect • Block the abnormal gene product protein • Give patient a therapeutic gene

  38. Gene Therapy for Heart Disease • Inject the gene for new blood vessel growth into the heart • All patients had improved angina and improved perfusion scans Losordo DW, et al, Circulation1998 Dec 22-29;98(25):2800-4 Pictures from MedScape – Daily news and feature updates

  39. Stem Cell Research to regenerate tissue and organs Slide from HSC Dr. Scherer’s presentation given in Madrid sponsored by RGA

  40. Summary • Heart disease mortality is improving • Watch for Metabolic X Syndrome traits • Issues with CI claims with troponins • Look at all Stress Test data – not just ST segment • Exciting new experimental therapies • Genetic medicine will help patients and doctors in the near future

  41. Thank you !

More Related